Amneal Pharmaceuticals
AMRX
AMRX
144 hedge funds and large institutions have $135M invested in Amneal Pharmaceuticals in 2023 Q1 according to their latest regulatory filings, with 9 funds opening new positions, 47 increasing their positions, 48 reducing their positions, and 21 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more funds holding in top 10
Funds holding in top 10: →
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less ownership
Funds ownership: →
8% less funds holding
Funds holding: 156 → 144 (-12)
33% less capital invested
Capital invested by funds: $202M → $135M (-$67.5M)
57% less first-time investments, than exits
New positions opened: 9 | Existing positions closed: 21
Holders
144
Holding in Top 10
1
Calls
$66K
Puts
$29K
Top Buyers
| 1 | +$6.05M | |
| 2 | +$1.22M | |
| 3 | +$695K | |
| 4 |
Citadel Advisors
Miami,
Florida
|
+$480K |
| 5 |
Allspring Global Investments
Charlotte,
North Carolina
|
+$453K |
Top Sellers
| 1 | -$5.34M | |
| 2 | -$3.67M | |
| 3 | -$3.15M | |
| 4 |
Millennium Management
New York
|
-$2.67M |
| 5 |
IA
IFP Advisors
Tampa,
Florida
|
-$1.97M |